Brazil Lab Targets Year-End Debut

Brazil Lab Targets Year-End Debut

Equity

Brazilian diagnostics laboratory company Fleury has unveiled key details of its plan to issue shares through an IPO, which is very likely going to be this year’s last initial offering. The deal will include a sale of 34.3m units at BRL15.00-BRL17.00.

Already have an account?

Free trial

Take a free two-week trial now for the latest news, data and market analysis.

Free Trial